Novel Clinical Data in Mantle Cell Lymphoma Highlighted in ASH 2025 Oral Session

Ingrid Glimelius, MD, PhD, Senior Consultant at Akademiska Hospital in Uppsala, Sweden, served as the moderator for Session 623, “Mantle Cell, Follicular, Waldenström’s, and Other Indolent B-Cell Lymphomas: Clinical and Epidemiological—Single-Agent and Combination Therapy for Mantle Cell Lymphoma.” In this MEDtalk, Ingrid Glimelius presents key Mantle Cell Lymphoma abstracts selected from the oral session at ASH 2025.